State Street’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $16K | Hold |
|
|||||
|
2024
Q3 | $149K | Hold |
|
|||||
|
2024
Q2 | $358K | Buy |
|
|||||
|
2024
Q1 | $313K | Buy |
|
|||||
|
2023
Q4 | $385K | Buy |
|
|||||
|
2023
Q3 | $131K | Hold |
|
|||||
|
2023
Q2 | $104K | Hold |
|
|||||
|
2023
Q1 | $88.5K | Hold |
|
|||||
|
2022
Q4 | $119K | Sell |
|
|||||
|
2022
Q3 | $213K | Buy |
|
|||||
|
2022
Q2 | $204K | Sell |
|
|||||
|
2022
Q1 | $1.36M | Sell |
|
|||||
|
2021
Q4 | $3.75M | Buy |
|
|||||
|
2021
Q3 | $4.99M | Buy |
|
|||||
|
2021
Q2 | $5.45M | Buy |
|
|||||
|
2021
Q1 | $5.95M | Buy |
|
|||||
|
2020
Q4 | $7.89M | Sell |
|
|||||
|
2020
Q3 | $15M | Buy |
|
|||||
|
2020
Q2 | $9.01M | Buy |
|
|||||
|
2020
Q1 | $3.87M | Sell |
|
|||||
|
2019
Q4 | $4.72M | Buy |
|
|||||
|
2019
Q3 | $7M | Buy |
|
|||||
|
2019
Q2 | $5.22M | Buy |
|
|||||
|
2019
Q1 | $3.85M | Buy |
|
|||||
|
2018
Q4 | $2.28M | Buy |
|
|||||
|
2018
Q3 | $4.55M | Buy |
|
|||||
|
2018
Q2 | $3.59M | Buy |
|
|||||
|
2018
Q1 | $2.62M | Buy |
|
|||||
|
2017
Q4 | $1.86M | Sell |
|
|||||
|
2017
Q3 | $2.83M | Buy |
|
|||||
|
2017
Q2 | $2.73M | Buy |
|
|||||
|
2017
Q1 | $976K | Buy |
|
|||||
|
2016
Q4 | $554K | Buy |
|
|||||
|
2016
Q3 | $347K | Buy |
|